Once-a-day Tacrolimus Conversion Study: The OneTAC Trial
Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
This study investigates the use of tacrolimus extended release in stable patients who have
undergone a heart transplant. All patients will receive the study medication free of charge
for the 1 year duration of the study.